Nav: Home

Current Radiotherapy News and Events

Current Radiotherapy News and Events, Radiotherapy News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 24 | 925 Results
Report: Progress in global cancer fight is not only possible, but achievable
The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable. (2019-10-16)
Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows. (2019-10-16)
Taking RTKI drugs during radiotherapy may not aid survival, worsens side effects
Taking certain cancer-fighting drugs while undergoing radiation therapy may not increase survival for patients, but may, instead, increase side effects, according to a team of researchers. (2019-10-10)
Study: Innovative pancreatic cancer treatment may rev up immune system
A research team at the University of Rochester Wilmot Cancer Institute reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to create an 'immune memory' in the same way that a vaccine keeps the flu away. (2019-10-08)
Men with prostate cancer can be spared radiotherapy after surgery
Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results of the RADICALS-RT trial presented at the ESMO Congress 2019 in Barcelona, Spain. (2019-09-27)
Men can be spared radiotherapy after surgery
Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results from a study led by The Royal Marsden NHS Foundation Trust. (2019-09-27)
Targeted radiotherapy technique could cut treatment time from two months to two weeks
Advanced radiotherapy technology could safely deliver curative treatment for some prostate cancer patients in just one or two weeks, according to new research published today. (2019-09-17)
Pre-salvage RT PSA predictive of hormone therapy benefit with salvage RT for recurrent prostate cancer
Initial results of NRG Oncology Clinical Trial RTOG 9601 in men with biochemically recurrent prostate cancer receiving salvage radiotherapy (SRT) demonstrated improvement in OS from the addition of long-term hormone therapy to SRT. (2019-09-16)
No difference in pain response between SBRT and conventional RT for patients with spinal metastases
A Phase III, NRG Oncology clinical trial that compared radiosurgery (SRS) or stereotactic body radiotherapy (SBRT) to the conventional radiotherapy (cEBRT) for patients with spinal metastases indicated that there was no statistically significant difference between the treatments for pain response, adverse events, FACT-G, BPI, and EQ-5D scores. (2019-09-16)
Cosmetic changes are equivalent after WBI vs PBI for women with early stage breast cancer
Results from the Quality of Life substudy of the NRG Oncology clinical trial NSABP B-39/RTOG 0413 indicate that women rated post-lumpectomy partial breast irradiation (PBI) as equivalent to whole breast irradiation (WBI) in terms of cosmetic outcomes and satisfaction from baseline to three years following radiotherapy treatment. (2019-09-16)
Bias against single people affects their cancer treatment
New research reveals the dangerous bias that's been buried in the fine print of academic and medical journals for more than 30 years. (2019-09-09)
Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy. (2019-09-03)
Moffitt researchers develop model to personalize radiation treatment
Moffitt Cancer Center researchers hope to change this mindset for radiation treatment with the development of a genomically-based model that can optimize and personalize a radiation dose to match an individual patient's needs. (2019-08-22)
Cancer survivors likely to face increase in long-term risk of cardiovascular disease
Survivors from a wide range of cancers could experience increased risks of heart disease and blood circulation problems compared to those who have never had cancer, according to new estimates published in the Lancet. (2019-08-20)
Chemotherapy drugs react differently to radiation while in water
In a new study in EPJ D, researchers at the Leopold-Franzens-University Innsbruck, in Innsbruck, Austria studied the way various molecules, found in chemotherapy drugs, react to ionization by radiation similar to that used in cancer treatment. (2019-08-07)
Adjuvant radiotherapy may be beneficial in treating locally advanced prostate cancer
Adjuvant radiotherapy administered after surgical removal of the prostate prolongs disease-free time as measured by PSA, a Finnish study shows. (2019-07-30)
Radiotherapy targets tumours precisely -- with less damage to healthy cells
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde. (2019-07-26)
Biomaterial-delivered chemotherapy leads to long-term survival in brain cancer
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered. (2019-07-18)
Hurricane disasters associated with poorer outcomes for radiotherapy patients
Lung cancer patients who had a hurricane disaster declared during radiotherapy had worse overall survival than those who completed treatment in normal circumstances. (2019-07-16)
Discovery of mechanism behind precision cancer drug opens door for more targeted treatment
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy. (2019-07-04)
One simple change cut unnecessary imaging for cancer patients in half
Most 'nudges' seek to increase a behavior, but this is one of the few employed to reduce it. (2019-06-27)
Radionuclide therapy effective in high-grade neuroendocrine neoplasms
Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 66th Annual Meeting. (2019-06-25)
Survivors of childhood brain tumors experience lasting cognitive and socioeconomic burdens
Survivors of childhood brain tumors who received radiotherapy and were very young at the time of diagnosis may experience cognitive and socioeconomic burdens decades after treatment, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (2019-06-24)
Testing therapies on mini-tumors of head and neck cancer
Head and neck cancer is an aggressive type of cancer that often recurs, despite patients undergoing harsh treatments. (2019-06-17)
Radiation treatment increases cardiac risk for lung cancer patients
As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure. (2019-06-10)
Scientists propose a fresh look at the role of ferroptosis in the development of cancer
Despite significant advances in medicine, cancer remains the second leading cause of death worldwide. (2019-06-06)
No increased risk of birth defects in children of fathers treated for testicular cancer
New research has found no increased risk of congenital malformations associated with treatment with radiotherapy or chemotherapy in children of fathers with testicular cancer. (2019-06-04)
Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment. (2019-06-03)
NRG oncology trial of metformin for non-small cell lung cancer
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC). (2019-06-01)
NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe
Results from the first experimental arm using veliparib as part of total neoadjuvant therapy (induction chemotherapy followed by chemoradiotherapy and surgery; TNT) in patients with locally advanced rectal adenocarcinoma on the NRG Oncology Phase II clinical trial NRG-GI002 were recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. (2019-06-01)
CNIO researchers discover a new way to protect against high-dose radiation damage
Intensive radiotherapy can be toxic in 60% of patients with tumors located in the gastrointestinal cavity. (2019-05-30)
Women in developing countries need radiotherapy and vaccines for cervical cancer
Millions of women in low- and middle-income countries will need life-saving radiotherapy to treat their cervical cancer, despite the growth of essential human papilloma virus (HPV) vaccination prevention programs. (2019-05-28)
Black men less likely than nonblack men to adopt active surveillance
At a time when a growing number of men with prostate cancer considered 'low risk' are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease. (2019-05-22)
Liquid biopsy could identify cancer patients at risk of metastatic disease
Analyzing fragments of DNA that are shed by tumors into the bloodstream, could indicate early on whether patients are at risk of their cancer spreading, according to new research presented today. (2019-05-15)
IL-1 inhibitors may reduce radiation-induced vascular damage
Radiation therapy against cancer can increase the risk of cardiovascular disease much later in life, as the radiation causes chronic inflammation of the exposed blood vessels. (2019-05-14)
ASTRO and AUA update joint clinical guidance for radiation therapy after prostatectomy
The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) today announced updates to their joint clinical guideline on adjuvant and salvage radiotherapy after prostatectomy in patients with and without evidence of prostate cancer recurrence to include new published research related to adjuvant radiotherapy. (2019-05-01)
EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer
Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer. (2019-04-30)
Researchers identify ways to predict and avoid radiotherapy side effects
Latest results from a project to discover what makes a cancer patient more likely to suffer adverse side effects after radiotherapy have shown that a combination of biological markers and certain genetic changes can predict radiation sensitivity. (2019-04-29)
Memory could be better protected in kids with brain tumors if treated with proton therapy
A comparison of three types of radiotherapy for children's brain tumors suggests that a type of proton therapy called pencil beam scanning offers the best hope of preserving cognitive functions. (2019-04-29)
Radiotherapy after chemo may improve survival in patients with advanced Hodgkin's lymphoma
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy even when all traces of the cancer appear to have gone, according to late-breaking results presented at the ESTRO 38 conference. (2019-04-28)
Page 1 of 24 | 925 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.